πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6664374

Polypeptides comprising IL-6 ligand-binding receptor domains

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6664263

1,8-naphthalimide imidazo{4,5,1-de}acridones with anti-tumor activity

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6664227

Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6660750

Flavopiridol methods and compositions for HIV therapy

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6660488

Antibodies for the alpha platelet-derived growth factor receptor

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6660273

Chimeric vaccine against tick-borne encephalitis virus

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6656930

Aralkyl diazabicycloalkane derivatives for CNS disorders

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6656706

Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6653505

3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Nov 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6653084

Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6649411

Methods of inhibiting cancer cells with ADNF III antisense oligonucleotides

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6641815

Sequestrin

The United States of America as represented by the Secretary of the Army Β· Granted Tue Nov 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6639060

erbB-3 nucleic acids

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6638514

Multivalent dengue virus vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6635614

Use of lecithin-cholesterol acyltransferase (LCAT) to reduce accumulation of cholesterol

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6632928

Immunotoxins and methods of inducing immune tolerance

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6632808

Inhibitors of amyloid formation

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6632640

Vaccine against Staphylococcus intoxication

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6632437

Immunogenic polysaccharide-protein conjugates containing poly &agr;(2→8), &agr;(2&#8

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6630507

Cannabinoids as antioxidants and neuroprotectants

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6630464

Cyclin dependent kinase (CDK)4 inhibitors and their use for treating cancer

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6630144

Monoclonal antibodies to Ebola glycoprotein

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6630124

Combination therapy with VIP antagonist

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6627641

Antimalarial naphthylisoquinoline alkaloids and pharmaceutical compositions and medical us

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired